sil'innov
0651.902.356 · rovalta.com · 25/09/2026
ACTIVE
sil'innov
Financial year 2024 · Closed on 31/12/2024
Net result-732,5 k €-5,3 %over 1 year
Gross margin-213,7 k €+3,2 %over 1 year
Equity-216,5 k €+72,9 %over 1 year
Workforce1,3 ETP0,0 %over 1 year
Overview
Identity
Source · BCE/KBOsil'innov is a Private limited company incorporated in 2016. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Courcelles. It employs on average 1,3 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0651.902.356
- Incorporation
- 14/04/2016
- Legal form
- Private limited company
- Registered office
- Rue de Liège(CO) 2
6180 Courcelles · WallonieSee on map - Contributed capital
- 434 562,00 €
- Latest accounts
- 31/12/2024
- Average workforce
- 1,3 ETP
Activities (NACE)
72101Research and experimental development on natural sciences and engineering· main72109Research and experimental development on natural sciences and engineering72110Research and experimental development on biotechnology72190Other research and experimental development on natural sciences and engineering70200Management consultancy activities70220Business and other management consultancy activities+6
Joint committees (1)
- 200
Signals
Healthy social debts
Financials
Source · NBB, 8 filingsTrend over 8 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -213,7 k € | +3.2% | -220,8 k € | -674% | 38,5 k € | -81.1% | 203,3 k € | +8.7% | 187 k € |
| EBITDA | -506,2 k € | -39.3% | -363,4 k € | -95.3% | -186,1 k € | +2.2% | -190,2 k € | -129% | -83,2 k € |
| Operating result | -760,2 k € | -22.7% | -619,4 k € | -44.9% | -427,5 k € | -8.1% | -395,5 k € | -84.2% | -214,8 k € |
| Net result | -732,5 k € | -5.3% | -695,4 k € | -44.5% | -481,1 k € | -22.6% | -392,6 k € | -566% | 84,3 k € |
| Balance sheet | |||||||||
| Equity | -216,5 k € | +72.9% | -799 k € | -671% | -103,6 k € | -127% | 377,6 k € | -51.0% | 770,1 k € |
| Total assets | 797,5 k € | -12.9% | 915,9 k € | -23.6% | 1,2 M € | -9.8% | 1,3 M € | +35.6% | 980 k € |
| Cash | 4,6 k € | -46.8% | 8,6 k € | -79.4% | 41,6 k € | -50.2% | 83,6 k € | -10.5% | 93,3 k € |
| Debts | 964,9 k € | -42.2% | 1,7 M € | +30.5% | 1,3 M € | +58.2% | 808,4 k € | +369% | 172,2 k € |
| Other | |||||||||
| Workforce | 1,3 ETP | 0.0% | 1,3 ETP | -35.0% | 2,0 ETP | -42.9% | 3,5 ETP | -38.6% | 5,7 ETP |
Board of directors
Source · NBB, accounts to 31/12/20241 active · 3 ended
Active mandates
Active
Ended mandates
Other companies at this address
Rue de Liège(CO) 2 6180 Courcelles| Company | CBE no. |
|---|---|
APR Pharma● Active | 0748.905.227 |
CFG Pharma● Active | 0746.821.410 |
EYTELIA● Active | 0456.542.178 |
PHIDEX CALN● Active | 0632.516.214 |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/09/2025 | 23/09/2024 | 05/10/2023 | 10/10/2022 | 30/09/2021 | 09/11/2020 |
| General meeting | 10/06/2025 | 11/06/2024 | 13/06/2023 | 14/06/2022 | 30/06/2021 | 01/10/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 10/06/2025 | 30/09/2025 | French | |
| Abridged model | 31/12/2023 | 11/06/2024 | 23/09/2024 | French | |
| Abridged model | 31/12/2022 | 13/06/2023 | 05/10/2023 | French | |
| Abridged model | 31/12/2021 | 14/06/2022 | 10/10/2022 | French | |
| Abridged model | 31/12/2020 | 30/06/2021 | 30/09/2021 | French | |
| Abridged model | 31/12/2019 | 01/10/2020 | 09/11/2020 | French | |
| Abridged model | 31/12/2018 | 11/06/2019 | 04/07/2019 | French | |
| Abridged model | 31/12/2017 | 28/06/2018 | 02/08/2018 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active · 3 ended
Active mandates
Active
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other09/10/2024STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - DIVERS
- Other25/06/2024DIVERS
- Mandates16/09/2021DEMISSIONS, NOMINATIONS
- Mandates02/01/2020MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
- Other03/08/2018STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
- Mandates30/12/2016DEMISSIONS, NOMINATIONS
- Other18/04/2016RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024-732,5 k €↓
- 2023Annual accounts 2023-695,4 k €↓
- 2022Annual accounts 2022-481,1 k €↓
- 2021Annual accounts 2021-392,6 k €↓
- 2020Annual accounts 202084,3 k €↑
- 2019Annual accounts 2019-433,7 k €↓
- 2018Annual accounts 2018-229,5 k €↑
- 2017Annual accounts 2017-456 k €
- 14/04/2016IncorporationPrivate limited company